IL142813A0 - Aromatic derivatives and iron complexes thereof for use as normalising agents of the iron level - Google Patents
Aromatic derivatives and iron complexes thereof for use as normalising agents of the iron levelInfo
- Publication number
- IL142813A0 IL142813A0 IL14281399A IL14281399A IL142813A0 IL 142813 A0 IL142813 A0 IL 142813A0 IL 14281399 A IL14281399 A IL 14281399A IL 14281399 A IL14281399 A IL 14281399A IL 142813 A0 IL142813 A0 IL 142813A0
- Authority
- IL
- Israel
- Prior art keywords
- iron
- normalising
- agents
- aromatic derivatives
- complexes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/04—Chelating agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pyrane Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT1998MI002350A IT1303688B1 (it) | 1998-11-02 | 1998-11-02 | Derivati aromatici e relativi complessi di fe(iii) atti all'usocome agenti normalizzanti del livello di ferro nell'organismo. |
PCT/EP1999/008222 WO2000026205A1 (en) | 1998-11-02 | 1999-10-29 | Aromatic derivatives and iron complexes thereof for the use as normalising agents of the iron level |
Publications (1)
Publication Number | Publication Date |
---|---|
IL142813A0 true IL142813A0 (en) | 2002-03-10 |
Family
ID=11380986
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14281399A IL142813A0 (en) | 1998-11-02 | 1999-10-29 | Aromatic derivatives and iron complexes thereof for use as normalising agents of the iron level |
IL142813A IL142813A (en) | 1998-11-02 | 2001-04-25 | Use of aromatic derivatives and iron complexes thereof in the preparation of pharmaceutical compositions for treating conditions to which an iron load is associated and pharmaceutical compositions comprising the same |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL142813A IL142813A (en) | 1998-11-02 | 2001-04-25 | Use of aromatic derivatives and iron complexes thereof in the preparation of pharmaceutical compositions for treating conditions to which an iron load is associated and pharmaceutical compositions comprising the same |
Country Status (17)
Country | Link |
---|---|
US (1) | US6455578B1 (it) |
EP (1) | EP1124814B1 (it) |
JP (1) | JP2002528539A (it) |
AR (1) | AR021037A1 (it) |
AT (1) | ATE229947T1 (it) |
AU (1) | AU756726B2 (it) |
BR (1) | BR9914863A (it) |
CA (1) | CA2348380C (it) |
CZ (1) | CZ299542B6 (it) |
DE (1) | DE69904635T2 (it) |
DK (1) | DK1124814T3 (it) |
ES (1) | ES2189537T3 (it) |
IL (2) | IL142813A0 (it) |
IT (1) | IT1303688B1 (it) |
PL (1) | PL198826B1 (it) |
SK (1) | SK286308B6 (it) |
WO (1) | WO2000026205A1 (it) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2001555A1 (de) * | 2006-03-29 | 2008-12-17 | Basf Se | Verwendung von strobilurinen zur behandlung von störungen des eisen-stoffwechsels |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4122200A (en) * | 1974-11-20 | 1978-10-24 | Lipha, Lyonnaise Industrielle Pharmaceutique | 6',2-(2'Arylchromonyl) propionic acids, and analgesic and anti-inflammatory derivatives thereof |
ATE14579T1 (de) * | 1979-03-20 | 1985-08-15 | Fisons Plc | Pharmazeutische heterocyclische verbindungen, verfahren zu ihrer herstellung und sie enthaltende zusammensetzungen. |
EP0346279A1 (de) * | 1988-06-06 | 1989-12-13 | Ciba-Geigy Ag | Propan-1,3-dionderivate und deren Verwendung als Stabilisatoren für chlorhaltige Polymerisate |
-
1998
- 1998-11-02 IT IT1998MI002350A patent/IT1303688B1/it active
-
1999
- 1999-10-29 AU AU11573/00A patent/AU756726B2/en not_active Ceased
- 1999-10-29 US US09/830,800 patent/US6455578B1/en not_active Expired - Fee Related
- 1999-10-29 DE DE69904635T patent/DE69904635T2/de not_active Expired - Lifetime
- 1999-10-29 DK DK99971418T patent/DK1124814T3/da active
- 1999-10-29 IL IL14281399A patent/IL142813A0/xx active IP Right Grant
- 1999-10-29 EP EP99971418A patent/EP1124814B1/en not_active Expired - Lifetime
- 1999-10-29 SK SK556-2001A patent/SK286308B6/sk not_active IP Right Cessation
- 1999-10-29 JP JP2000579593A patent/JP2002528539A/ja active Pending
- 1999-10-29 WO PCT/EP1999/008222 patent/WO2000026205A1/en active IP Right Grant
- 1999-10-29 CA CA002348380A patent/CA2348380C/en not_active Expired - Fee Related
- 1999-10-29 ES ES99971418T patent/ES2189537T3/es not_active Expired - Lifetime
- 1999-10-29 AR ARP990105492A patent/AR021037A1/es unknown
- 1999-10-29 BR BR9914863-3A patent/BR9914863A/pt not_active Application Discontinuation
- 1999-10-29 PL PL347940A patent/PL198826B1/pl not_active IP Right Cessation
- 1999-10-29 CZ CZ20011461A patent/CZ299542B6/cs not_active IP Right Cessation
- 1999-10-29 AT AT99971418T patent/ATE229947T1/de not_active IP Right Cessation
-
2001
- 2001-04-25 IL IL142813A patent/IL142813A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
BR9914863A (pt) | 2001-07-03 |
CZ20011461A3 (cs) | 2001-08-15 |
PL347940A1 (en) | 2002-04-22 |
EP1124814B1 (en) | 2002-12-18 |
CA2348380A1 (en) | 2000-05-11 |
PL198826B1 (pl) | 2008-07-31 |
AU1157300A (en) | 2000-05-22 |
AR021037A1 (es) | 2002-06-12 |
CA2348380C (en) | 2009-02-17 |
DE69904635D1 (de) | 2003-01-30 |
WO2000026205A1 (en) | 2000-05-11 |
ATE229947T1 (de) | 2003-01-15 |
EP1124814A1 (en) | 2001-08-22 |
DK1124814T3 (da) | 2003-04-14 |
SK5562001A3 (en) | 2001-09-11 |
SK286308B6 (en) | 2008-07-07 |
IL142813A (en) | 2006-12-10 |
IT1303688B1 (it) | 2001-02-23 |
DE69904635T2 (de) | 2003-10-02 |
JP2002528539A (ja) | 2002-09-03 |
CZ299542B6 (cs) | 2008-08-27 |
ITMI982350A1 (it) | 2000-05-02 |
AU756726B2 (en) | 2003-01-23 |
US6455578B1 (en) | 2002-09-24 |
ES2189537T3 (es) | 2003-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0103349A3 (en) | Phthalazine derivatives as phosphodiesterase 4 inhibitors | |
GB9701206D0 (en) | Serine derivatives and their use as therapeutic agents | |
PL352755A1 (en) | Imidazoimidazoles and triazoles as anti-inflammatory agents | |
PL340254A1 (en) | Derivatives of pleuromutillin as antimicrobial agents | |
PL351764A1 (en) | Aromatic heterocyclic compounds as antiinflammatory agents | |
HUP0202477A3 (en) | Use of phthalazine derivatives | |
HUP0200724A3 (en) | Indigoid bisindole derivatives and pharmaceurical compositions containing them | |
HUP0100870A3 (en) | Alpha-aminoamide derivatives useful as analgesic agents | |
GB0004167D0 (en) | 1-piperidinyl-propan-2-ol derivatives and their use as therapeutic agents | |
PL336348A1 (en) | Indazolamide compounds as serotoninergic agents | |
IL139490A0 (en) | Phthalazine derivatives as phosphodiesterase 4 inhibitors | |
PL340305A1 (en) | Composition of agents reducing the level of lipoides | |
PL332616A1 (en) | Hydoxymethylhexanones as odorising and savourising agents | |
IL147891A0 (en) | Topical use of anti-muscarnic agents | |
HUP0203611A3 (en) | 14,15-beta-methylene substituted androgens and their use for preparation of the medicaments | |
HK1042847A1 (zh) | 骨代謝異常症治療劑 | |
HUP0204208A3 (en) | Antipruritic agents for external use | |
IL142813A0 (en) | Aromatic derivatives and iron complexes thereof for use as normalising agents of the iron level | |
HUP9902883A3 (en) | Bis/acridinecarboxamide/ and bis/phenazinecarboxamide/ derivatives as antitumour agents, preparation and use thereof | |
SI1124814T1 (en) | Aromatic derivatives and iron complexes thereof for the use as normalising agents of the iron level | |
IL129858A0 (en) | The use of polyether-polyurethane for safety clothing | |
HK1033128A1 (en) | Benzo[c]quinolzine derivatives and their use as 5 alpha-reductases inhibitors | |
HUP0102506A3 (en) | The use of benzothiophene derivatives for increasing the level of acetylcholine | |
EP0910356A4 (en) | BIPHENYLAMIDO DERIVATIVES AS MELATONERGIC AGENTS | |
EP1233772A4 (en) | Boron compounds and complexes as anti-inflammatories |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KB | Patent renewed | ||
FF | Patent granted | ||
KB | Patent renewed |